GLOBUS MEDICAL INC
Company Stats
- Market Cap
- $10.1B
- as of Sep 30, 2026
- Shares Outstanding
- 134.3M
- Free Float
- 99.5%
Income Statement
- Revenue
- $2.9B
- Operating Income
- $479.8M
- Net Income
- $537.9M
- EBITDA
- $756.7M
- Revenue Growth, 3Y
- 42.2%
- FCF Margin, 3Y Avg
- 15.6%
- FCF Margin, Worst Year
- 10.5%
Cash Flow
- Free Cash Flow
- $588.8M
- FCF Yield
- 5.9%
- Owner FCF Yield
- 5.4%
Balance Sheet
- Cash & Equivalents
- $526.2M
Returns & Capital
- Share Repurchases
- $300.5M
- Buyback Yield, 3Y Avg
- 2.0%
- SBC, 3Y Avg
- $52.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.9B | $588.8M | 20.0% |
| FY2024 | $2.5B | $405.2M | 16.1% |
| FY2023 | $1.6B | $165.2M | 10.5% |
| FY2022 | $1.0B | $104.4M | 10.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back